Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers -
TR Rebbeck, AM Levin, A Eisen, C Snyder, P Watson, … - jnci, 1999 - jnci.oxfordjournals.org
... was associated with a statistically significantly reduced risk of developing breast
cancer in the total sample (HR = 0.53; 95% CI = 0.33-0.84; Table 2 Go). ...
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study. -
DM Schreinemachers, RB Everson - Epidemiology, 1994 - JSTOR
... For women less than 50 years of age at the time of NHANES I, aspirin use was associated
with a reduced risk of breast cancer (IRR = 0.54; 95% CI = 0.33-0.89). ...
… therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast … -
AP Forrest, HJ Stewart, D Everington, RJ Prescott, … - Lancet, 1996 - ncbi.nlm.nih.gov
... due to fewer loco-regional relapses (HR 0.20, 95% CI 0.12-0.33). ... INTERPRETATION:
After local excision of a primary breast cancer, we conclude that radiotherapy ...
Factors Associated With Surgical and Radiation Therapy for Early Stage Breast Cancer in Older Women -
R Ballard-Barbash, AL Potosky, LC Harlan, SG … - jnci, 1996 - jnci.oxfordjournals.org
... or more compared with women 65?69 years of age and OR of 0.33 [95% CI ... among women
aged 65 years or more who were diagnosed with early stage breast cancer. ...
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal … -
RT Chlebowski, SL Hendrix, RD Langer, ML Stefanick … - JAMA, 2003 - geisingermedicalcenter.com
... on Breast Cancer and Mammography ... These results suggest estrogen plus progestin may
stimulate breast can- cer growth and hinder breast cancer diagnosis. JAMA. ...
Premenopausal Breast Cancer Risk and Intake of Vegetables, Fruits, and Related Nutrients -
JL Freudenheim, JR Marshall, JE Vena, R Laughlin, … - jnci, 1996 - jnci.oxfordjournals.org
... nutrients were as follows: vitamin C (OR = 0.53; 95% CI = 0.33?0.86), tocopherol ...
No association was found between breast cancer risk and intake of vitamins C ...
… Reduction Reveals High-Order Interactions among Estrogen-Metabolism Genes in Sporadic Breast Cancer -
MD Ritchie, LW Hahn, N Roodi, LR Bailey, WD Dupont … - The American Journal of Human Genetics, 2001 - Elsevier
... of the method, MDR was then applied to the sporadic?breast cancer data set ... two-locus
models had a mean ? SEM prediction error of 21.91%?0.33%), whereas the ...
… cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical … -
AA Ross, BW Cooper, HM Lazarus, W Mackay, TJ Moss, … - Blood, 1993 - bloodjournal.hematologylibrary.org
... taminated PBSC specimens was 0.8/1 O5 mononuclear cells (range 0.33 to 2.0/105 ... cells
than paired BM specimens from patients with advanced breast cancer and that ...
… Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from … -
PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, … - jnci, 2005 - jnci.oxfordjournals.org
... letrozole arm and 22 in the placebo arm, a combination of breast cancer and nonprotocol ...
taken tamoxifen for more than 5 years (HR = 0.56, 95% CI = 0.33 to 0.97 ...
A Prospective Study of Folate Intake and the Risk of Breast Cancer -
S Zhang, DJ Hunter, SE Hankinson, EL Giovannucci, … - JAMA, 1999 - Am Med Assoc
... least 600 ?g/d and breast cancer risk among women consuming at least 15 g/d of alcohol
was present among both premenopausal (RR=0.65; 95% CI, 0.33-1.28) and ...
Source: Google Scholar |